Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Viavi Solutions falls as investors digest recent $500M-plus equity offering and dilution overhang

None

Viavi Solutions Inc. (VIAV) is down 5.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued digestion of VIAVI’s recently completed large common-stock offering, which increased share count and was priced at a discount to prior trading levels. After a sharp run-up in recent weeks, the added supply and “financing overhang” can also trigger profit-taking even without new negative operating news.

Details:

  • VIAVI priced an underwritten public offering of 11,111,111 shares at $45.00 per share, implying roughly $500 million in gross proceeds before fees and expenses.
  • The prospectus materials indicated the company expected to use net proceeds largely to repay a $450 million Term Loan B, shifting the capital structure but also creating near-term dilution for equity holders.
  • An SEC filing disclosed the offering structure included an option for underwriters to purchase up to 1,666,666 additional shares, which can add to supply expectations around the deal window.
  • VIAVI also recently announced it completed an acquisition of Spirent’s High-Speed Ethernet, Network Security, and Channel Emulation business, and investors may be reassessing integration and balance-sheet priorities alongside the equity raise.
  • Sources:

    SEC, PR Newswire, VIAVI Solutions (Investor Relations)

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $VIAV Insider Trading Activity

    VIAV Insider Trades

    $VIAV insiders have traded $VIAV stock on the open market 44 times in the past 6 months. Of those trades, 0 have been purchases and 44 have been sales.

    Here’s a breakdown of recent trading of $VIAV stock by insiders over the last 6 months:

    • OLEG KHAYKIN (President & CEO) has made 0 purchases and 17 sales selling 778,038 shares for an estimated $22,558,635.
    • RICHARD BELLUZZO has made 0 purchases and 3 sales selling 79,943 shares for an estimated $3,493,105.
    • ILAN DASKAL (EVP, CFO) has made 0 purchases and 3 sales selling 170,000 shares for an estimated $2,972,993.
    • GARY W STALEY (SVP Global Sales NSE) has made 0 purchases and 7 sales selling 90,069 shares for an estimated $2,289,155.
    • KEVIN CHRISTOPHER SIEBERT (SVP Gen. Counsel & Secretary) has made 0 purchases and 4 sales selling 53,321 shares for an estimated $1,490,125.
    • LUKE M SCRIVANICH (SVP General Manager OSP) has made 0 purchases and 3 sales selling 24,594 shares for an estimated $936,356.
    • DONALD A COLVIN sold 25,000 shares for an estimated $730,750
    • DOUG GILSTRAP sold 10,000 shares for an estimated $550,000
    • PAUL MCNAB (EVP, Chief Mktg & Stgy Officer) has made 0 purchases and 3 sales selling 10,916 shares for an estimated $386,328.
    • RICHARD JOHN BURNS sold 3,384 shares for an estimated $63,483
    • EUGENIA CORRALES sold 3,384 shares for an estimated $63,483

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive VIAV Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $VIAV Hedge Fund Activity

    We have seen 259 institutional investors add shares of $VIAV stock to their portfolio, and 223 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $VIAV Congressional Stock Trading

    Members of Congress have traded $VIAV stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

    Here’s a breakdown of recent trading of $VIAV stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $VIAV Analyst Ratings

    Wall Street analysts have issued reports on $VIAV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Needham issued a "Buy" rating on 01/29/2026
    • Stifel issued a "Buy" rating on 12/17/2025

    To track analyst ratings and price targets for $VIAV, check out Quiver Quantitative's $VIAV forecast page.

    $VIAV Price Targets

    Multiple analysts have issued price targets for $VIAV recently. We have seen 6 analysts offer price targets for $VIAV in the last 6 months, with a median target of $56.5.

    Here are some recent targets:

    • Ryan Koontz from Needham set a target price of $68.0 on 04/30/2026
    • Mehdi Hosseini from Susquehanna set a target price of $65.0 on 04/30/2026
    • Andrew Spinola from UBS set a target price of $60.0 on 04/30/2026
    • Dave Kang from B. Riley Securities set a target price of $53.0 on 04/24/2026
    • Mike Genovese from Rosenblatt set a target price of $42.0 on 03/18/2026
    • Ruben Roy from Stifel set a target price of $24.0 on 01/29/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles